In recent years, marked advances, which can be regarded as curative. have become evident in the treatment of inoperable semimalignant gliomas (I-II WHO). In this context interstitial irradiation -and specifically the pennanent in~lantation of 192 IR and 125 O -has proved to be very effective. Survival times of 12 years or more with a 5-year survival time of ~ have been reported (Mundinger et al. in:Dietz et al, Klinische Neurochirurgie. Stuttgt., p.519-565,1983) .Cemplete remissions of 2 years have so far been observed by us (Oppel,F. H.W.Pannek. J. Voges. in: Samii M.(ed) Tumors in and around the brain-stem and the third ventricle. Berlin, 1985-in press ). On the other hand, this therapy has proved to he unsuccessful, however, for malignant gliemas (III-IV WHO). The authors reperttheir results in 20 patients with the method of fractionated afterloading in association with percutaneeus irradiation (external beam) they developed for inoperable ma%~gnant brain tuners. This s~alled afterloading technique is an intracavitery radiotherapy with highly active radionuclides. An emitter is introduced by computer control (Buchler-unit) into a super-refined steel tube previously implanted in the longitudinal tm~or axis. and the tumor is irradiated "from inside". This procedure offers the following advantages: I. The spatial dose distribution can be adjusted to the size and shape of the tumer. 2. A relatively high radiation dose can be delivered to the center of the tumor (spatially superselective). 3. Radiologically favourable fractionation is achieved by application of up to 15 single doses (per dose 2 Gy). 4. Undesirable protracted effects of irradiation are safely avoided. 5. High radiation volume is ensumed to association with percutaneeus irradiation. The case control studies (12 months at the time of su~ission of this abstract) of CT-scans showed a regression of the tumor with an irradiation necrosis in the previous tumor area. These results correlate with continuously decreasing neurological defects and the patient's good general condition.
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TREATMENT (G.Seifert, J.Caselitz, Cancer Detection and Prevention 8, 23, 1985) . Origin of the malignant proliferation is mostly the terminal ductal system (indifferent cell of the reserve cell type). High differentiated malignant tumors are characterized by the persistence of markers of the ductal cells with secretory functions (lactoferrin, lysozyme, secretory component), by the expression of many lect~ receptors (PNA, HPA, ConA, etc.) and the occurrence of blood group substances (A.B.H.Le). This pattern of tumor markers can be observed in adenocarcinomas, adenoid cystic and salivary duct carcinomas, mucoepidermoid tumors and carcinomas in pleomorphic adenomas. The occurrence of myoepithelial cells in some types of tumors (adenoid cystic carcinomas, salivary duct carcinomas etc.) can be defined by a staining of antin, myosin and S-IO0 protein, the co-expression of keratin and vimentin and the presence of basal membrane associated substances (lamiain, fibroaectin, elastin). Acinic cell tumors show a posy tive reaction for amylase. Further aspects are the evidence of hormonal markers, the occurrence of growth factor receptors or the use of viral and chromosomal markers. 
